Second cash injection, 850 000 USD, due to milestone achievements in bioactivity and cardiovascular effect studies shown in ischemic rat models.
You are here:
Second cash injection, 850 000 USD, due to milestone achievements in bioactivity and cardiovascular effect studies shown in ischemic rat models.
| Copyright © Eribis Pharmaceuticals. Developed by dreamforce.se. This web site uses cookies. Read more. |